Prithu Sundd on The Role of CD39 Polymorphism in Enabling Pulmonary Thrombosis in SCD
Prithu Sundd, Senior Investigator and Professor-Thrombosis and Hemostasis Program at Versiti Blood Research Institute, shared on LinkedIn:
”Very excited to share our new work on the role of CD39 polymorphism and extracellular vesicles in promoting in situ pulmonary thrombosis in Sickle Cell Disease.
Special thanks to hard work of Tomasz Brzoska, Tomasz Kaminski and SM Nouraie.
Thanks to all the collaborators, Sickle Cell Centers at PITT/UPMC and MCW/Froedtert.
Thanks to CTRO, Versiti Research, Walk-PHASST study, and NHLBI TOPMed VTE working group for their support.”
Read the full article here.
Article: CD39 polymorphism enables lung thrombosis in sickle cell disease
Authors: Tomasz Brzoska, Tomasz W. Kaminski, Omika Katoch, Elizaveta V. Menchikova, Adekunle E. Alagbe, Sarah E. Tashbook, Stevan P. Tofovic, Jude C. Jonassaint, Claudette M. St. Croix, Simon C. Watkins, Shane Howe, Joshua J. Field, Amanda A. Seyerle, Tirthadipa Pradhan-Sundd, Cecilia Laurie, Nathan D. Pankratz, Nicholas L. Smith, Ellen L. Goode, James S. Pankow, Charles Kooperberg, Gregory J. Kato, Yingze Zhang, Enrico M. Novelli, Mark T. Gladwin, Edwin K. Jackson, Seyed M. Nouraie, Prithu Sundd
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 16, 2026, 13:15Paul Bolaji Invites You to Join World Stroke Organization Membership
-
Jan 16, 2026, 12:46Gregory Piazza on The Effect of Enduring Risk Factors in Provoked VTE
-
Jan 16, 2026, 12:33Fernando Corrales-Medina on Heavy Periods in Teens: Don’t Miss a Bleeding Disorder
-
Jan 16, 2026, 06:05Wolfgang Miesbach on Jacob Lund’s Study: How to Define FVIII Bioequivalence
-
Jan 16, 2026, 05:52Piotr Czempik Shares His Latest Contribution to Acta Haematologica Polonic
-
Jan 16, 2026, 05:44Florian Piekarski on Perioperative Blood Management When Allogeneic Transfusion is Not Aaccepted
-
Jan 16, 2026, 05:00Plaque Rupture and Thrombosis
-
Jan 16, 2026, 04:52Arterial Disease Across Vascular Beds․ Lipoprotein(a) as a Causal Risk Factor
-
Jan 16, 2026, 04:51Higher-Dose Clotting Factor Prophylaxis Does Not Reduce Postpartum Hemorrhage in Women with von Willebrand Disease